Patents by Inventor Murray Bailey

Murray Bailey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrocyclic peptides active against the hepatitis C virus
    Publication number: 20050192212
    Abstract: Compounds of formula (I): wherein R1, R2, X, R3, D, and the dotted line b are as defined herein; or a pharmaceutically acceptable salt or ester thereof, are useful as inhibitors of the HCV NS3 protease.
    Type: Application
    Filed: January 19, 2005
    Publication date: September 1, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Montse Llinas-Brunet, Murray Bailey, Punit Bhardwaj, Francois Bilodeau, Pasquale Forgione, Elise Ghiro, Nathalie Goudreau, Teddy Halmos, Jean Rancourt
  • Macrocyclic peptides active against the hepatitis C virus
    Publication number: 20050080005
    Abstract: Compounds of formula I: wherein D, R4, R3, L0, L1, L2, R2 and Rc are defined herein; or a pharmaceutically acceptable salt thereof, useful as inhibitors of the HCV NS3 protease.
    Type: Application
    Filed: September 20, 2004
    Publication date: April 14, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Montse Llinas-Brunet, Murray Bailey, Punit Bhardwaj, Pasquale Forgione, Elise Ghiro, Nathalie Goudreau, Teddy Halmos, Jean Rancourt
  • Macrocyclic peptides active against the hepatitis C virus
    Publication number: 20050075279
    Abstract: Compounds of formula (I): wherein R1 is (C1-8)alkyl, (C3-7)cycloalkyl, {(C1-6)alkyl-(C3-7)cycloalkyl} or Het, which are all optionally substituted from 1 to 3 times with halo, cyano, nitro, O—(C1-6)alkyl, amido, amino or phenyl, or R1 is C6 or C10 aryl which is optionally substituted from 1 to 3 times with halo, cyano, nitro, (C1-6)alkyl, O—(C1-6)alkyl, amido, amino or phenyl; or a pharmaceutically acceptable salt thereof, useful as an inhibitor of the HCV NS3 protease.
    Type: Application
    Filed: October 16, 2003
    Publication date: April 7, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Montse Llinas-Brunet, Murray Bailey
  • Hepatitis C inhibitor compounds
    Publication number: 20050020503
    Abstract: Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
    Type: Application
    Filed: May 20, 2004
    Publication date: January 27, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Montse Llinas-Brunet, Murray Bailey, Punit Bhardwaj, Josee Bordeleau, Pasquale Forgione, Elise Ghiro, Vida Gorys, Nathalie Goudreau, Sylvie Goulet, Teddy Halmos, Jean Rancourt